Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
I cannot express how grateful I am for Blue Sky
The GLP-1-only mechanism produces a different side effect profile, and the semaglutide versus tirzepatide comparison can help you evaluate which might suit your physiology better
If you buy something via one of our links, we may earn a commission
Biohacking culture People want to optimize performance and longevity Social media influence Peptides are widely promoted as recovery shortcuts Frustration with slow healing = lack of education by providers on how long tendon/ligament injuries can take to repair Athletes often seek ways to speed recovery beyond natural timelines A Major Concern: Unregulated Products Currently: most peptides are not approved by Health Canada or the FDA manufacturing is largely unregulated quality control is inconsistent This makes it difficult to verify: product purity dosing accuracy contamination risk Current Medical Consensus Peptides show biological promise in preclinical research but lack sufficient human evidence for routine clinical use Important unknowns include: dosing frequency duration long-term safety How Group23 Approaches Regenerative Medicine At Group23 Sports Medicine, we focus on treatments supported by the strongest evidence: structured rehabilitation programs under physiotherapy supervision load management and strength training ideally with strength and conditioning coach platelet-rich plasma (PRP) soft tissue adapted biocompatible hyaluronic acid injections SportVis see www.sportvis.ca high molecular weight cross linked hyaluronic acid injections Monovisc (see www.monovisc.ca), Synolis VA (see www.synolis.com) and Durolane (www.durolane.ca/en/) Blood Flow Restriction (BFR) therapy (see off the shelf and custom bracing strategies These treatments currently have far stronger clinical evidence than experimental peptide therapies
These data suggest that GSH-mediated effects in the expansion, survival, and antitumor activity of CD8 + T cells are dependent primarily on GPX4
